Ibogaine therapy for substance abuse disorders

Deborah C. Mash

Research output: Chapter in Book/Report/Conference proceedingChapter

10 Scopus citations

Abstract

Introduction Ibogaine is a naturally occurring psychoactive indole alkaloid derived from the roots of the rainforest shrub Tabernanthe iboga.Ibogaine is used by indigenous peoples of Western Africa in low doses to combat fatigue, hunger, and thirst, and in higher doses as a sacrament in religious rituals (Goutarel et al., 1991). The use of ibogaine for the treatment of drug dependence was based on anecdotal reports by groups of self-treating addicts that the drug blocked opiate withdrawal and reduced craving for opiates, cocaine, and other illicit drugs for extended time periods (Shepard, 1994; Alper et al., 1999). Preclinical studies supported these early claims and provided proof-of-concept in animal models (Dzoljic et al., 1988; Glick et al., 1992). Addiction is a behavioral pattern of drug abuse characterized by compulsive use, loss of behavioral control, and a high tendency to relapse. An integrated medical, psychosocial, and spiritual treatment is often needed to achieve recovery in addicted patients. Ibogaine is a unique pharmacotherapy for the treatment of substance abuse disorders because it fosters a life change or may work as a transition-based therapy similar to the goals set in the 12-step fellowship programs. While ibogaine's effects on behavior are complex, the beneficial actions of the drug on withdrawal symptoms and cravings are because of an interaction of the active metabolite noribogaine with neurotransmitters in the brain reward and addiction circuit.

Original languageEnglish (US)
Title of host publicationClinical Addiction Psychiatry
PublisherCambridge University Press
Pages50-60
Number of pages11
ISBN (Electronic)9780511782107
ISBN (Print)9780521899581
DOIs
StatePublished - Jan 1 2010

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Ibogaine therapy for substance abuse disorders'. Together they form a unique fingerprint.

  • Cite this

    Mash, D. C. (2010). Ibogaine therapy for substance abuse disorders. In Clinical Addiction Psychiatry (pp. 50-60). Cambridge University Press. https://doi.org/10.1017/CBO9780511782107.007